Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Three TB Chemoprophylaxis Regimens in HIV/TB Co-infected Patients
NCT00402454Phase 4Completed
- Sponsor
- Sociedad Andaluza de Enfermedades Infecciosas
- Start
- Jan 1994
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Tuberculosis (TB) comparing Isoniazid 6m, Rifampin + Isoniazid 3m and Rifampin + Pyrazinamide 2m (3 arms). Primary endpoints: Development of Tuberculosis and Suspension of chemoprophylaxis due to adverse effects. Started Jan 1994; status: completed.
02
Drugs
isoniazidrifampicinpyrazinamide
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00402454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402454.